Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/23/2012CN102091185B Medicinal liquor for treating rheumatism and preparation method thereof
05/23/2012CN102085282B Traditional Chinese medicine composition for treating hypophrenia and senile dementia and preparation method and detection method thereof
05/23/2012CN102078591B Series of medicines for mental negative by using four-step treatment method
05/23/2012CN102058769B Traditional Chinese medicine for treating yin deficiency and internal heat type schizophrenia and preparation method thereof
05/23/2012CN102040556B Optical isomers of indene quinazoline, preparation method and medicinal application thereof
05/23/2012CN102018952B Tablet for nourishing liver, protecting liver, sobering up and strengthening kidney and preparation process thereof
05/23/2012CN102008588B Medicine composition for curing hepatic encephalopathy and hepatitis B
05/23/2012CN102002441B Plant balm for improving physical and mental harmonious degree
05/23/2012CN102000298B Medicament for treating headache during menstruation
05/23/2012CN102000275B Medicinal composition for treating children with tic disorders and preparation method thereof
05/23/2012CN102000121B Cordyceps militaris oligopeptide composition as well as preparation method and use thereof
05/23/2012CN101991769B Traditional Chinese medicine composition for treating heart-kidney imbalance
05/23/2012CN101991729B Medicinal liquor for relaxing muscles and tendons
05/23/2012CN101982168B Quercetin nano-micelle preparation and preparation method thereof
05/23/2012CN101966193B Application of 2,3,5,4-tetrahydroxystilbene-2-O-beta-D-glucoside to preparing medicaments for treating depression
05/23/2012CN101948539B IL-18 binding proteins
05/23/2012CN101947242B Preparation method of deproteinized calf blood extract
05/23/2012CN101933932B Application of 4-cyan-beta-D-glucoside in treating chronic neurogenic pain
05/23/2012CN101926980B Application of cytotoxin (CTX1) from snake venom to preparation of medicament for rehabilitating
05/23/2012CN101919978B Traditional Chinese medicine composition, preparation method and application thereof
05/23/2012CN101899466B Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
05/23/2012CN101829303B Longevity wine
05/23/2012CN101829133B Application of 7-O-beta-D-acetylation sugar-coumarin in treating depression
05/23/2012CN101829132B Application of 7-O-beta-D-acetylation sugar-coumarin compounds in treating chronic neuropathic pains
05/23/2012CN101829128B Application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains
05/23/2012CN101829126B Application of 3-carbethoxy phenyl-beta-D-glucoside in treating chronic neuropathic pains
05/23/2012CN101816756B Chinese medicinal composition for treating upset and irritability and preparation method thereof
05/23/2012CN101810658B Method for removing residual pesticide from ginseng
05/23/2012CN101797236B Rivastigmine orally disintegration tablet and preparation method thereof
05/23/2012CN101797228B Method for preparing oryzanol microemulsion
05/23/2012CN101791287B Solid oral drug composite containing aripiprazole microcrystalline
05/23/2012CN101781292B E-ring substituted silybin derivative and preparation method and medical application thereof
05/23/2012CN101773644B Traditional Chinese medicine for moxa treatment of neurodynia after paraplegia
05/23/2012CN101773563B Medicine composition
05/23/2012CN101766662B Process for efficiently concentrating cordycepin
05/23/2012CN101744940B Topical ointment of traditional Chinese medicine and preparation method thereof used for curing pains on head and face
05/23/2012CN101744765B Bulleyaconitine A multivesicular liposome and preparation method thereof
05/23/2012CN101732331B Composite of monostalotetrahexosylgangliside and glutamate
05/23/2012CN101721510B Medicine composition for treating headache or migraine and preparation method thereof
05/23/2012CN101708255B Chinese medicinal composition for treating depression
05/23/2012CN101690588B Composition comprising probiotics and tea extract and application thereof
05/23/2012CN101676287B 6-(substituted phenoxy)-tetrazolo[5,1-a] phthalazine derivatives as antuepileptics and their pharmaceutically acceptable salts
05/23/2012CN101669637B Application of cornflower-3-O-galactoside in preparing foods or medicaments for improving cognitive functions of old people
05/23/2012CN101664558B Chitosan-collagen-diprospan slow releasing system, preparation method and application thereof
05/23/2012CN101664491B Medicament for treating arthralgia-synadrome and preparation method thereof
05/23/2012CN101658494B Huperzine A solid lipid nano particle and preparation method thereof
05/23/2012CN101648009B Method for preparing cordycepin SOD medicinal granules
05/23/2012CN101641353B Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
05/23/2012CN101616925B Tricyclic compounds and their use as glucocorticoid receptor modulators
05/23/2012CN101601664B Therapeutic patch comprising capsaicin and method for preparing the same
05/23/2012CN101590163B Medicament for treating dementia and preparation method thereof
05/23/2012CN101505732B Low dose sublingual tablets of opioid analgesics and preparation process
05/23/2012CN101467984B Tramadol gel for nose as well as preparation method and application thereof
05/23/2012CN101429134B New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof
05/23/2012CN101395152B Sigma receptor compounds
05/23/2012CN101385796B New use of a formulation in improving cognition dysfunction and preventing and treating senile dementia
05/23/2012CN101366720B Pharmaceutical uses of polyene phosphatidyl choline for treating cognitive impairment
05/23/2012CN101336226B Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
05/23/2012CN101270359B Method for preparing recombined human amyloid A beta 42 and application thereof
05/23/2012CN101269103B Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis
05/23/2012CN101227823B Method for preparing concentration components of tetrahydro tetrahydroxy curcumin and tetrahydroxy curcumin from curcuma extractive
05/23/2012CN101217943B Prolonged release formulation of active principles
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101103013B 1-thio-D-glucitol derivatives
05/23/2012CN101061098B Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183266 Methods
05/22/2012US8183256 Remedy or preventive for integration dysfunction syndrome
05/22/2012US8183231 Substituted propane phosphinic acid derivatives
05/22/2012US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
05/22/2012US8182837 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
05/22/2012CA2632949C Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
05/22/2012CA2546302C Combination of flupirtine and tramadol
05/22/2012CA2508069C Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/22/2012CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy
05/22/2012CA2459033C Methods for inhibiting cognitive deterioration in adults with down's syndrome
05/22/2012CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands
05/22/2012CA2440884C Transdermal patch for administering fentanyl
05/22/2012CA2427502C Novel primers for screening schizophrenia and a method thereof
05/18/2012WO2012065110A2 S-protected cysteine analogs and related compounds
05/18/2012WO2012065106A2 Compounds and related methods for manipulating parp-1-dependent cell death
05/18/2012WO2012065102A2 S-t-butyl protected cysteine di-peptide analogs and related compounds
05/18/2012WO2012064892A1 Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
05/18/2012WO2012064836A1 Methods and compositions for neural disease immunotherapy
05/18/2012WO2012064715A1 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/18/2012WO2012064667A2 Treatment of addiction and impulse-control disorders using pde7 inhibitors
05/18/2012WO2012064269A1 COMPOUNDS AND THEIR USE FOR TREATMENT OF Αβ-RELATED DISEASES
05/18/2012WO2012064088A2 Pharmaceutical composition including polymer microsphere containing olanzapine as active ingredient
05/18/2012WO2012063513A1 Method of treatment for mental disorders
05/18/2012WO2012063207A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012WO2012063007A1 Factor h for treating autoimmune diseases of the nervous system
05/18/2012WO2012062783A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012WO2012062759A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062751A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062750A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062687A1 Triazole derivatives and their use for neurological disorders
05/18/2012WO2012062623A1 Triazole derivatives as ligands for gaba receptors
05/18/2012WO2012062439A1 Dosing regimen for sedation with cns 7056 (remimazolam)
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1833